Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | KDM5A | P29375 | 2/20 | 0.43 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | ICMT | O60725 | 1/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1478275 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL486755 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL8688351 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL22645993 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL22642596 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL23940310 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL22646107 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL22806624 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL22806605 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL10989638 | 1.00 | LMNA (0.52) | LMNAALDH1A1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118390136-A | High-temperature nickel-free sealing agent for aluminum alloy anodic oxide film and preparation method thereof | 华南理工大学 | 2024-07-26 | — | — | CN | claimed |
| US-4016115-A | Unsaturated polyester resin composition containing titanium dioxide | TOYO BOSEKI KABUSHIKI KAISHA (JA) | 1977-04-05 | — | — | US | claimed |
| US-12545636-B2 | Acyclic lipids and methods of use thereof | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3638678-B1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS | MODERNATX INC (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4655402-A1 | NUCLEIC ACID VACCINES FOR VARICELLA-ZOSTER VIRUS (VZV) | Providence Therapeutics Holdings Inc. (CA) | 2025-12-03 | — | — | EP | disclosed |
| US-12486444-B2 | Synergistic performance of amine blends in shale control | HUNTSMAN PETROCHEMICAL LLC | 2025-12-02 | — | — | US | disclosed |
| EP-4036079-B1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS | MODERNATX INC (US) | 2025-11-19 | — | — | EP | disclosed |
| WO-2025228979-A1 | LIPIDS NANOPARTICLE FORMULATIONS SUITABLE FOR LUNG TARGETING | NEOVAC LTD. (GB) | 2025-11-06 | — | — | WO | disclosed |
| EP-3986977-B1 | SYNERGISTIC PERFORMANCE OF AMINE BLENDS IN SHALE CONTROL | HUNTSMAN PETROCHEMICAL LLC (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250313525-A1 | CONSTRAINED LIPIDS AND METHODS OF USE THEREOF | RENAGADE THERAPEUTICS MAN INC (US) | 2025-10-09 | — | — | US | disclosed |
| US-4973610-A | CONTAINING BLOWING AGENT, BROMINE COMPOUND, AMMONIUM COMPOUND, AND AMINE | BASF AKTIENGESELLSCHAFT (DE) | 1990-11-27 | — | — | US | disclosed |
| EP-0395981-A1 | Expandable styrene polymers | BASF Aktiengesellschaft (DE) | 1990-11-07 | — | — | EP | disclosed |
| US-4892620-A | SIZING AGENT FOR PAPER | ATOCHEM (FR) | 1990-01-09 | — | — | US | disclosed |
| EP-0232196-B1 | DIURETHANE LATEX AS A SIZING AGENT IN THE PAPER INDUSTRY, AND ITS PROCESS OF PRODUCTION | ELF ATOCHEM S.A. (FR) | 1989-09-13 | — | — | EP | disclosed |
| US-4786330-A | SIZING AGENT FOR PAPER | ATOCHEM (FR) | 1988-11-22 | — | — | US | disclosed |
| EP-0232196-A1 | Diurethane latex as a sizing agent in the paper industry, and its process of production | ELF ATOCHEM S.A. (FR) | 1987-08-12 | — | — | EP | disclosed |
| US-4663063-A | OIL AND FUEL ADDITIVES | THE LUBRIZOL CORPORATION (US) | 1987-05-05 | — | — | US | disclosed |
| US-4086191-A | ORGANIC BROMINE NUCLEATING AGENT | BASF AKTIENGESELLSCHAFT (DT) | 1978-04-25 | — | — | US | disclosed |
| US-4016115-A | Unsaturated polyester resin composition containing titanium dioxide | TOYO BOSEKI KABUSHIKI KAISHA (JA) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313525-A1 | CONSTRAINED LIPIDS AND METHODS OF USE THEREOF | SGMS1, SGMS2, LNPEP | LMNA 755/4885ALDH1A1 4876/4885TSHR 2825/4885 |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | APOB, APOL1, LDLR | LMNA 161/4885ALDH1A1 3260/4885TSHR 3848/4885 |
| US-12545636-B2 | Acyclic lipids and methods of use thereof | PLTP, LNPEP, PCTP | LMNA 458/4885ALDH1A1 4885/4885TSHR 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.